お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界の臨床検査市場:市場規模、シェア、および動向、およびセグメント予測(タイプ・最終用途別)
市場調査レポート
商品コード
421217

世界の臨床検査市場:市場規模、シェア、および動向、およびセグメント予測(タイプ・最終用途別)

Clinical Laboratory Tests Market Size, Share & Trends Analysis Report By Type (CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c, CMP, Liver Panel, Renal Panel, Lipid Panel), By End Use, And Segment Forecasts, 2020 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 90 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
世界の臨床検査市場:市場規模、シェア、および動向、およびセグメント予測(タイプ・最終用途別)
出版日: 2020年02月18日
発行: Grand View Research, Inc.
ページ情報: 英文 90 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界の臨床検査市場について調査しており、市場動向、成長や見通し、主要取引、タイプ・最終用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査方法と範囲

  • 市場のセグメンテーションと範囲
  • 市場の定義
  • 情報調達
  • 情報分析
  • 市場の定式化とデータの視覚化
  • データの検証と公開

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合の洞察

第3章 市場変数、動向、および規模

  • 市場系の見通し
  • 浸透と成長の見通しのマッピング
  • コスト構造分析
  • 償還の枠組み
  • 市場力学
  • 市場分析ツール
  • PESTEL分析
  • 主要取引と戦略的提携分析

第4章 競合情勢

  • 世界の主要企業、最近の開発、産業への影響
  • 企業/競合のカテゴリー(主要イノベーター、市場リーダー、新興企業)
  • 公開会社
  • 民間企業

第5章 市場分析:タイプ別

  • 定義と範囲
  • 市場シェア分析
  • ダッシュボード
  • 世界市場
  • 市場規模と予測、および動向分析
    • 血算
    • HGB / HCT
    • 基礎代謝パネル
    • BUNクレアチニン
    • 電解質
    • HbA1c
    • 総合代謝パネル
    • 肝パネル
    • 腎パネル
    • 脂質パネル

第6章 市場分析:最終用途別

  • 定義と範囲
  • 市場シェア分析
  • ダッシュボード
  • 世界市場
  • 市場規模と予測、および動向分析
    • 中央研究所
    • プライマリークリニック

第7章 市場分析:地域別

  • 市場のスナップショット
  • 地域の市場シェアと主要企業
  • 要因別SWOT分析(政治的、法的、経済的、技術的)
  • 市場規模、予測、動向分析

第8章 企業プロファイル

  • 戦略の枠組み
図表

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 North America Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 3 North America Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 4 North America Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 5 North America Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 6 North America Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 7 U.S. Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 8 U.S. Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 9 U.S. Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 10 U.S. Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 11 Canada Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 12 Canada Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 13 Canada Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 14 Canada Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 15 Europe Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 16 Europe Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 17 Europe Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 18 Europe Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 19 Europe Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 20 U.K. Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 21 U.K. Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 22 U.K. Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 23 U.K. Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 24 Germany Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 25 Germany Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 26 Germany Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 27 Germany Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 28 France Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 29 France Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 30 France Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 31 France Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 32 Italy Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 33 Italy Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 34 Italy Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 35 Italy Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 36 Spain Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 37 Spain Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 38 Spain Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 39 Spain Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 40 Russia Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 41 Russia Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 42 Russia Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 43 Russia Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 44 Asia Pacific Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 45 Asia Pacific Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 46 Asia Pacific Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 47 Asia Pacific Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 48 Asia Pacific Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 49 Japan Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 50 Japan Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 51 Japan Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 52 Japan Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 53 China Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 54 China Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 55 China Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 56 China Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 57 India Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 58 India Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 59 India Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 60 India Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 61 Australia Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 62 Australia Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 63 Australia Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 64 Australia Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 65 South Korea Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 66 South Korea Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 67 South Korea Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 68 South Korea Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 69 Singapore Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 70 Singapore Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 71 Singapore Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 72 Singapore Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 73 Latin America Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 74 Latin America Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 75 Latin America Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 76 Latin America Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 77 Latin America Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 78 Mexico Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 79 Mexico Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 80 Mexico Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 81 Mexico Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 82 Brazil Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 83 Brazil Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 84 Brazil Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 85 Brazil Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 86 Argentina Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 87 Argentina Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 88 Argentina Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 89 Argentina Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 90 MEA Clinical Laboratory Tests Market, by Country, 2016 - 2027 (USD Billion)
  • TABLE 91 MEA Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 92 MEA Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 93 MEA Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 94 MEA Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 95 South Africa Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 96 South Africa Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 97 South Africa Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 98 South Africa Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 99 UAE Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 100 UAE Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 101 UAE Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 102 UAE Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 103 Saudi Arabia Clinical Laboratory Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 104 Saudi Arabia Liver Panel Tests Market, by Type, 2016 - 2027 (USD Billion)
  • TABLE 105 Saudi Arabia Clinical Laboratory Tests Market, by End-use, 2016 - 2027 (USD Billion)
  • TABLE 106 Saudi Arabia Clinical Laboratory Tests End-use Market, by Type, 2016 - 2027 (USD Billion)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Summary
  • Fig. 4 Market Segmentation & Scope
  • Fig. 5 Market Size and Growth Prospects
  • Fig. 6 Global Clinical Laboratory Tests- Key Market Driver Analysis
  • Fig. 7 Global Clinical Laboratory Tests Market - Key Market Restraint Analysis
  • Fig. 8 Penetration & Growth Prospect Mapping
  • Fig. 9 Global Clinical Laboratory Tests Market - Porter's Analysis
  • Fig. 10 Global Clinical Laboratory Tests Market - PESTEL Analysis
  • Fig. 11 Global Clinical Laboratory Tests Market Type Outlook Key Takeaways
  • Fig. 12 Global Clinical Laboratory Tests Market: Type Movement Analysis
  • Fig. 13 Complete Blood Count Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 14 HGB/HCT Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 15 Basic Metabolic Panel Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 16 Bun Creatinine Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 17 Electrolytes Testing Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 19 Hba1c Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 20 Comprehensive Metabolic Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 21 Liver Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 22 Hepatitis Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 23 Bile Duct Obstruction Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 24 Liver Cirrhosis Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 25 Liver Cancer Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 26 Bone Disease Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 27 Autoimmune Disorder Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 28 Others Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 29 Renal Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 30 Lipid Panel Tests Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 31 Global Clinical Laboratory Tests Market End-Use Outlook Key Takeaways
  • Fig. 32 Global Clinical Laboratory Tests Market: End-Use Movement Analysis
  • Fig. 33 Central Laboratories Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 34 Primary Clinics Market Estimates, 2016 - 2027 (USD Billion)
  • Fig. 35 Regional Marketplace: Key Takeaways
  • Fig. 36 Global Clinical Laboratory Tests Market: Regional Movement Analysis
  • Fig. 37 North America Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 38 U.S. Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 39 Canada Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 40 Europe Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 41 U.K. Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 42 Germany Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 43 France Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 44 Spain Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 45 Italy Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 46 Russia Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 47 Asia Pacific Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 48 Japan Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 49 China Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 50 India Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 51 South Korea Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 52 Singapore Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 53 Australia Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 54 Latin America Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 55 Brazil Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 56 Mexico Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 57 Argentina Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 58 MEA Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 59 South Africa Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 60 UAE Market, 2016 - 2027 (USD Billion)
  • Fig. 61 Saudi Arabia Clinical Laboratory Tests Market, 2016 - 2027 (USD Billion)
  • Fig. 62 Strategy Framework
目次
Product Code: 978-1-68038-361-4

The global clinical laboratory tests market size is expected to reach USD 304.9 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.1% over the forecast period. Introduction of new solutions for minimizing errors and maximizing efficiency is anticipated to boost the overall market growth.

Presence of favorable reimbursement plans for laboratory tests is anticipated to positively influence the global market. According to an article published in the American Clinical Laboratory Association (ACLA), these tests are reimbursed by Medicare payees either under the Physician Fee Schedule or Clinical Laboratory Fee Schedule based on the nature of service.

According to an article published in Forbes, in 2018, the new clinical lab fee schedule reduced their overall payments by 10% as compared to 2017 for tests that represent nearly two-thirds of Medicare's outlays for laboratory tests.

In addition, growing demand for early detection of several diseases is anticipated to drive the clinical laboratory tests market over the forecast period. For instance, biochips are used for preparing thousands of DNA, RNA, or protein samples that can be processed on a single chip at the same time. According to an article published in the American Clinical Laboratory Association, more than 7 billion clinical laboratory examinations are performed each year in U.S.

Presence of major players such as QIAGEN, Laboratory Corporation of America Holdings, Siemens Healthcare GmbH, Quest Diagnostics Incorporated, and Abbott is expected to fuel the market growth. These companies are involved in undertaking initiatives such as product development, strategic collaborations, and regional expansion.

In November 2019, QIAGEN entered into a strategic agreement with Laboratory Corporation of America Holdings to extend its existing QIAGEN Clinical Insights license. Moreover, in August 2018, QIAGEN collaborated with SRL, Inc., Japan's largest clinical testing lab company, to prepare for the introduction of novel companion diagnostic tests along with new drug approvals.

Further key findings from the report suggest:

In 2019, basic metabolic panel dominated the type segment owing to the increasing prevalence of lifestyle-induced diseases

Lipid panel is projected to register a CAGR of 8.0% over the forecast period owing to rising incidences of cardiovascular disorders globally

In 2019, hepatitis dominated the liver panel segment whereas liver cirrhosis is estimated to be the fastest-growing sub-segment over the forecast period

Central laboratories dominated the overall market in 2019 owing to the expansion of key laboratories such as Q2 Solutions and Pharmaceutical Product Development, LLC

Primary clinics is anticipated to register a significant CAGR of 7.6% from 2020 to 2027 owing to advancements such as portable and rapid diagnostic tests

North America dominated the global market in 2019 owing to the increasing geriatric population and high disease prevalence

Asia Pacific is projected to be the fastest-growing market over the forecast period owing to improving healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Market definition
  • 1.3. Information procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third-party perspectives
    • 1.3.4. Primary research
  • 1.4. Information analysis
    • 1.4.1. Data analysis models
  • 1.5. Market formulation & data visualization
  • 1.6. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Clinical Laboratory Tests Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Cost Structure Analysis
  • 3.4. Reimbursement Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market driver analysis
      • 3.5.1.1. Rising geriatric population base
      • 3.5.1.2. Growing prevalence of target diseases
      • 3.5.1.3. Introduction of innovative solutions
      • 3.5.1.4. Rising demand for early disease detection
    • 3.5.2. Market restraint analysis
      • 3.5.2.1. Presence of ambiguous regulatory framework
  • 3.6. Clinical Laboratory Tests Market Analysis Tools
    • 3.6.1. Industry analysis - Porter's
      • 3.6.1.1. Supplier Power: Moderate due to large number of diagnostic test manufacturers
      • 3.6.1.2. Buyer Power: Moderate due to presence of players entering into long-term contract
      • 3.6.1.3. Substitution Threat: Low due to no/less external substitutes
      • 3.6.1.4. Threat from new entrants: Moderate due to brand recognition of the existing players
      • 3.6.1.5. Competitive rivalry: High due to increasing mergers & acquisitions by major players
  • 3.7. PESTEL Analysis
    • 3.7.1. Political landscape
    • 3.7.2. Environmental landscape
    • 3.7.3. Social landscape
    • 3.7.4. Technology landscape
    • 3.7.5. Legal landscape
  • 3.8. Major Deals & Strategic Alliances Analysis
    • 3.8.1. Joint ventures
    • 3.8.2. Mergers & acquisitions
    • 3.8.3. Licensing & partnership
    • 3.8.4. Technology collaborations
    • 3.8.5. Strategic divestments

Chapter 4. Clinical Laboratory Tests Market - Competitive Analysis

  • 4.1. Recent developments & impact analysis, by key market participants
  • 4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.3. Public Companies
    • 4.3.1. Company market position analysis
    • 4.3.2. Company market share/ranking, by region
    • 4.3.3. Competitive dashboard analysis
    • 4.3.4. Market differentiators
    • 4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
  • 4.4. Private Companies
    • 4.4.1. List of key emerging companies
    • 4.4.2. Regional network map
    • 4.4.3. Company market position analysis

Chapter 5. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Type market share analysis, 2019 & 2027
  • 5.3. Type Dashboard
  • 5.4. Global Clinical Laboratory Test Market, by Type, 2016 to 2027
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 5.5.1. Complete blood count
    • 5.5.2. HGB/HCT testing
    • 5.5.3. Basic metabolic panel testing
    • 5.5.4. BUN creatinine testing
    • 5.5.5. Electrolytes testing
    • 5.5.6. HbA1c testing
    • 5.5.7. Comprehensive metabolic panel testing
    • 5.5.8. Liver panel testing
      • 5.5.8.1. Hepatitis
      • 5.5.8.2. Bile duct obstruction
      • 5.5.8.3. Liver Cirrhosis
      • 5.5.8.4. Liver Cancer
      • 5.5.8.5. Bone disease
      • 5.5.8.6. Autoimmune disorders
      • 5.5.8.7. Others
    • 5.5.9. Renal panel testing
    • 5.5.10. Lipid panel testing

Chapter 6. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. End-use market share analysis, 2019 & 2027
  • 6.3. End-use Dashboard
  • 6.4. Global Clinical Laboratory Test Market, by End-use, 2016 to 2027
  • 6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
    • 6.5.1. Central Laboratories
      • 6.5.1.1. Complete blood count
      • 6.5.1.2. HGB/HCT testing
      • 6.5.1.3. Basic metabolic panel testing
      • 6.5.1.4. BUN creatinine testing
      • 6.5.1.5. Electrolytes testing
      • 6.5.1.6. HbA1c testing
      • 6.5.1.7. Comprehensive metabolic panel testing
      • 6.5.1.8. Liver panel testing
      • 6.5.1.9. Renal panel testing
      • 6.5.1.10. Lipid panel testing
    • 6.5.2. Primary Clinics
      • 6.5.2.1. Complete blood count
      • 6.5.2.2. HGB/HCT testing
      • 6.5.2.3. Basic metabolic panel testing
      • 6.5.2.4. BUN creatinine testing
      • 6.5.2.5. Electrolytes testing
      • 6.5.2.6. HbA1c testing
      • 6.5.2.7. Comprehensive metabolic panel testing
      • 6.5.2.8. Liver panel testing
      • 6.5.2.9. Renal panel testing
      • 6.5.2.10. Lipid panel testing

Chapter 7. Clinical Laboratory Tests Market: Regional Estimates & Trend Analysis, by Type, End-Use and End-Use by Type

  • 7.1. Regional Market Snapshot
  • 7.2. Regional Market Share and Leading Players, 2019
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Size, & Forecasts, and Trend Analysis, 2019 to 2027
    • 7.4.1. North America
      • 7.4.1.1. U.S.
      • 7.4.1.2. Canada
    • 7.4.2. Europe
      • 7.4.2.1. U.K.
      • 7.4.2.2. Germany
      • 7.4.2.3. Spain
      • 7.4.2.4. France
      • 7.4.2.5. Italy
      • 7.4.2.6. Russia
    • 7.4.3. Asia Pacific
      • 7.4.3.1. China
      • 7.4.3.2. Japan
      • 7.4.3.3. India
      • 7.4.3.4. South Korea
      • 7.4.3.5. Singapore
      • 7.4.3.6. Australia
    • 7.4.4. South America
      • 7.4.4.1. Brazil
      • 7.4.4.2. Mexico
      • 7.4.4.3. Argentina
    • 7.4.5. Middle East Africa
      • 7.4.5.1. South Africa
      • 7.4.5.2. Saudi Arabia
      • 7.4.5.3. UAE

Chapter 8. Company Profiles

  • 8.1. Strategic Framework
    • 8.1.1. Abbott
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial framework
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. ARUP Laboratories
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial framework
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. OPKO Health, Inc.
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial framework
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Bioscientia Institut fur Medizinische Diagnostik GmbH
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial framework
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Charles River
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial framework
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. Neogenomics Laboratories, Inc. (Clarient, Inc.)
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial framework
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Genoptix, Inc.
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial framework
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Healthscope
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial framework
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. Labco S.A
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial framework
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. Laboratory Corporation of America Holdings (LabCorp)
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial framework
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives
    • 8.1.11. QIAGEN
      • 8.1.11.1. Company overview
      • 8.1.11.2. Financial framework
      • 8.1.11.3. Product benchmarking
      • 8.1.11.4. Strategic initiatives
    • 8.1.12. Quest Diagnostics
      • 8.1.12.1. Company overview
      • 8.1.12.2. Financial framework
      • 8.1.12.3. Product benchmarking
      • 8.1.12.4. Strategic initiatives
    • 8.1.13. Siemens Healthcare Private Limited
      • 8.1.13.1. Company overview
      • 8.1.13.2. Financial framework
      • 8.1.13.3. Product benchmarking
      • 8.1.13.4. Strategic initiatives
    • 8.1.14. Sonic Healthcare
      • 8.1.14.1. Company overview
      • 8.1.14.2. Financial framework
      • 8.1.14.3. Product benchmarking
      • 8.1.14.4. Strategic initiatives
    • 8.1.15. Fresenius Medical Care Holdings, Inc.
      • 8.1.15.1. Company overview
      • 8.1.15.2. Financial framework
      • 8.1.15.3. Product benchmarking
      • 8.1.15.4. Strategic initiatives
    • 8.1.16. Merck KgaA
      • 8.1.16.1. Company overview
      • 8.1.16.2. Financial framework
      • 8.1.16.3. Product benchmarking
      • 8.1.16.4. Strategic initiatives
    • 8.1.17. Tulip Diagnostics
      • 8.1.17.1. Company overview
      • 8.1.17.2. Financial framework
      • 8.1.17.3. Product benchmarking
      • 8.1.17.4. Strategic initiatives
    • 8.1.18. Biosino Bio-technology and Science Inc.
      • 8.1.18.1. Company overview
      • 8.1.18.2. Financial framework
      • 8.1.18.3. Product benchmarking
      • 8.1.18.4. Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.